Investigating sleep regulation in Smith-Magenis Syndrome

Circadian and homeostatic regulation of sleep in a diurnal model of Smith-Magenis Syndrome

NIH-funded research University of Michigan at Ann Arbor · NIH-11102461

This study is looking at how sleep works in people with Smith-Magenis Syndrome, who often have trouble sleeping, by using a special rodent model to learn more about the brain's role in sleep and how light and melatonin might help improve sleep for those with the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-11102461 on NIH RePORTER

What this research studies

This research explores how sleep is regulated in individuals with Smith-Magenis Syndrome (SMS), a condition that often leads to significant sleep disturbances. By using a diurnal rodent model created through advanced gene editing techniques, the study aims to uncover the neural mechanisms that contribute to these sleep issues. The researchers will examine the effects of light and melatonin on sleep patterns, which may help to understand the underlying causes of sleep problems in SMS. The ultimate goal is to identify potential interventions that could improve sleep and, consequently, behavioral challenges associated with the syndrome.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Smith-Magenis Syndrome who experience sleep disturbances.

Not a fit: Patients without Smith-Magenis Syndrome or those who do not experience sleep-related issues may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved sleep and reduced behavioral issues for patients with Smith-Magenis Syndrome.

How similar studies have performed: Previous research has shown promising results in understanding sleep disturbances in neurodevelopmental disorders, suggesting that this approach could yield valuable insights.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 17p- syndromeautism-fragile X (AFRAX) syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.